NDAINJECTIONINJECTABLE
Approved
Oct 1962
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
DECA-DURABOLIN (nandrolone decanoate) by Teva is clinical pharmacology anabolic steroids are synthetic derivatives of testosterone. First approved in 1962.
Drug data last refreshed 8h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Deca-Durabolin (nandrolone decanoate) is a synthetic anabolic steroid derivative of testosterone administered via intramuscular injection. It works by mimicking male sex hormone activity to promote anabolic effects, though complete dissociation from androgenic effects has not been achieved. The drug has been used clinically since 1962 for various therapeutic indications requiring anabolic support.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), likely indicating a contracting team and focus on cost management and generic transition strategies.
Mechanism of Action
CLINICAL PHARMACOLOGY Anabolic steroids are synthetic derivatives of testosterone. Certain clinical effects and adverse reactions demonstrate the androgenic properties of this class of drugs. Complete dissociation of anabolic and androgenic effects has not been achieved. The actions of anabolic…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
38 enrolled
HIV InfectionsHIV Wasting Syndrome
Career Relevance
Working on Deca-Durabolin as a Teva-sponsored product approaching loss of exclusivity offers limited growth trajectory and declining headcount opportunities. Roles focus on defensive commercial strategies, regulatory compliance, and transition management rather than innovative product development or market expansion.
Worked on DECA-DURABOLIN at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.